Article Information
- Received May 30, 2001
- Revision received July 6, 2001
- Accepted July 12, 2001
- First published October 1, 2001.
- Version of record published October 1, 2001.
Author Information
Author contributions
Disclosures
- Received May 30, 2001.
- Revision received July 6, 2001.
- Accepted July 12, 2001.
This work was supported by the Howard Hughes Medical Institute (D.W., N.S.M., and N.C.R.), the National Alliance for Research on Schizophrenia and Depression, the Department of Veterans Affairs (P.S. and S.S.W.), and National Science Foundation Grant IBN97201 (J.G.H.). We thank Sumitomo Pharmaceuticals for the generous donation of DOPS, R. Steiner for use of his facilities and reagents, C. Bjornson and D. Kimelman for the use of their digital camera and technical advice, G. Mies for technical advice, and D. Kim and M. Szczypka for critical reading of this manuscript.
Correspondence should be addressed to Dr. Richard D. Palmiter, Howard Hughes Medical Institute, Biochemistry, Box 357370, University of Washington, Seattle, WA 98195. E-mail:palmiter{at}u.washington.edu.
Online Impact